When a person has a stroke, every minute that passes without treatment increases the likelihood of significant loss of cognitive abilities, according to Dr. Sandra Ruby, medical director of Carroll Hospital Center's stroke program. That's what makes the hospital's new designation as a primary stroke center so important. "We've been taking care of stroke patients for years, but what the designation will provide for us at this point is it will allow EMS to bring patients with stroke symptoms to us directly," Ruby said. "EMS are mandated to take patients they recognize as having stroke symptoms to the nearest designated stroke center." What that meant previously, Ruby said, is that when an ambulance picked up a stroke patient in Carroll County, they would be taken out of county to the nearest primary stroke center, be that Sinai or Northwest hospitals near Baltimore or Frederick Memorial Hospital. Given the importance of beginning treatment as soon as possible, Ruby said it's no small improvement for a Westminster stroke victim to be seen in Westminster rather than spending an hour or more traveling out of county. Hospitals are certified as designated stroke centers by the Maryland Institute for Emergency Medical Services Systems, or … Continue reading →

(PRWEB) April 02, 2015 New York Dynamic Neuromuscular Rehabilitation & Physical Therapy clinic is introducing for the first time in New York City, a groundbreaking, conservative method of treatment for patients who have suffered from a stroke (or other types of neurological diseases that damage the ability to walk, balance, and bear weight). A stroke is considered a cerebrovascular accident (CVA) that causes an obstruction of blood supply to the brain tissue resulting in damage to the nerve cells. Damage to the nerve cells can cause a variety of side effects, such as an inability to walk, loss of balance, inability to smile, and difficulty with speech. Approximately 800,000 people suffer from strokes every year; it is the third leading cause of death in the United States. With these alarming statistics, it is vital for patients to seek out the most advanced therapy treatments possible. At NYDNRehab, they look at each patient as an individual and customize a multimodal plan using their high tech therapy options. Their technology has the ability to diagnose deficits in neuromuscular and cognitive control. In addition, they use both gait analysis and Computer Assisted Rehabilitation Environment (CAREN) to assess the motor function of their patients. … Continue reading →

SIOUX CITY | Mercy Medical Center has received the American Heart Association/American Stroke Association's Get With The GuidelinesTarget: Stroke Honor Roll Quality Achievement Award at the association's International Stroke Conference. The award recognizes the hospital's commitment and success ensuring that stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence. Mercy is one of 559 hospitals to be recognized on the Target: Stroke Honor Roll, among the nearly 1,000 hospitals given quality achievement awards at the conference. To receive the award, hospitals must meet quality measures developed to reduce the time between the patient's arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. If given intravenously in the first three hours after the start of symptoms, tPA has been shown to significantly reduce the effects of stroke and lessen the chance of permanent disability. Over three months or greater, at least 50 percent of the hospital's ischemic stroke patients have received tPA within 60 minutes of arriving at the hospital. Mercy has also met specific scientific guidelines as a Primary Stroke … Continue reading →

People differ in the size and composition of their chromosomes, which can affect the test results IMAGE:This is conceptual art of maternal blood screening of fetal DNA. view more Credit: Alice C Gray Prenatal blood screening for extra or missing chromosomes in the fetus might give false-positive results if the mother's genome contains more than the usual number of certain DNA segments. This finding is reported April 1 in the New England Journal of Medicine. The article is part of a collection of papers examining screening tests now available to patients due to recent advances in genome sciences. Researchers at the University of Washington, Fred Hutchinson Cancer Research Institute, and the Howard Hughes Medical Institute worked together to analyze false-positive results from the newer prenatal genetic screens. Dr. Hilary Gammill, UW assistant professor of obstetrics and gynecology and research associate at Fred Hutchinson Cancer Research Institute, and Dr. Jay Shendure, UW professor of genome sciences, are the senior authors of the study. The lead authors are Matthew W. Snyder, UW genome sciences graduate student, and Dr. Lavone Simmons, former UW fellow in maternal-fetal medicine. The newer prenatal genetic screens analyze cell-free DNA circulating in the mother's blood during pregnancy. The … Continue reading →

Orthopedic Stem Cell Therapy for Arthritic Joint Pain Dr. Sergio Viroslav, board certified orthopedic surgeon and joint replacement specialist with The San Antonio Orthopaedic Group, appeared on Great Day SA on March 30th, 2015 to discuss the... By: The San Antonio Orthopaedic Group … Continue reading →

Can PRP and Stem Cell Therapy Help You? | Orlando Orthopaedic Center How can PRP and stem cell therapy help you heal? Orlando Orthopaedic Center's Dr. Matthew R. Willey explains. For more visit http://www.OrlandoOrtho.com. By: OrlandoOrtho … Continue reading →

DALLAS, April 2, 2015 /PRNewswire/ -- Lifescienceindustryresearch.com adds "Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report" in its store. Recent months have seen the first iPSC clinical trial in humans, creation of the world's largest iPSC Biobank, major funding awards, a historic challenge to the "Yamanaka Patent", a Supreme Court ruling affecting industry patent rights, the announcement of an iPSC cellular therapy clinic scheduled to open in 2019, and much more. Furthermore, iPSC patent dominance continues to cluster in specific geographic regions, while clinical trial and scientific publication trends give clear indicators of what may happen in the industry in 2015 and beyond. Is it worth it to get informed about rapidly-evolving market conditions and identify key industry trends that will give an advantage over the competition? BrowsetheReportComplete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Reportathttp://www.lifescienceindustryresearch.com/complete-2013-14-induced-pl .... Induced pluripotent stem cells represent a promising tool for use in the reversal and repair of many previously incurable diseases. The cell type represents one of the most promising advances discovered within the field of stem cell research during the past decade, making this a valuable industry report for both companies and investors to claim in order to optimally position themselves to … Continue reading →